COLL vs DOCU · P/E 17, rev $181.9M vs P/E 15, rev $2.98B
Collegium Pharmaceutical Inc (COLL) versus DocuSign Inc (DOCU) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
DocuSign Inc (DOCU) is a software - application company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Not investment advice. Open the COLL and DOCU stock pages for the full models.
Not investment advice.